Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses

Jung Min Lee, John L. Hays, Christina M. Annunziata, Anne M. Noonan, Lori Minasian, Jo Anne Zujewski, Minshu Yu, Nicolas Gordon, Jiuping Ji, Tristan M. Sissung, William D. Figg, Nilofer Azad, Bradford J. Wood, James Doroshow, Elise C. Kohn

Research output: Contribution to journal › Article › peer-review

142 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses'. Together they form a unique fingerprint.

Medicine & Life Sciences